Donal J Brennan

Title: Donal J Brennan: Innovator in Breast Cancer Treatment Prediction

Introduction

Donal J Brennan is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of medical research, particularly in the area of breast cancer treatment prediction. His innovative approach aims to enhance the effectiveness of endocrine treatments for patients.

Latest Patents

Donal J Brennan holds a patent for a method titled "Treatment prediction involving HMGCR." This invention provides a systematic approach for determining whether a mammalian subject with breast cancer is likely to benefit from endocrine treatment. The method involves evaluating a sample obtained from the subject, assessing the amount of HMGCR protein or mRNA present, and comparing this value to a reference value. If the sample value exceeds the reference, it indicates that the subject may benefit from the treatment. This patent represents a significant advancement in personalized medicine for breast cancer patients.

Career Highlights

Brennan is associated with Atlas Antibodies AB, where he continues to contribute to innovative research in the field of cancer treatment. His work focuses on developing methods that can lead to more effective treatment options for patients suffering from breast cancer.

Collaborations

Throughout his career, Donal J Brennan has collaborated with esteemed colleagues such as Mathias Uhlen and Fredrik Ponten. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.

Conclusion

Donal J Brennan's contributions to breast cancer treatment prediction exemplify the impact of innovation in medicine. His patent and ongoing work at Atlas Antibodies AB highlight the importance of research in improving patient outcomes.